Diana Ernst, RPh

Most Recent Articles by Diana Ernst, RPh

Health Experts Review and Rank Best Overall Diets for 2019

Health Experts Review and Rank Best Overall Diets for 2019

By

An expert panel assessed 41 diets to come up with their final results, examining the evidence behind each diet's claims, the short-term and long-term weight loss associated with the diet, how easy the diet is to follow, how well each diet conforms to current nutrition standards, and its effect on diabetes and cardiovascular disease prevention.

Reversal of Warfarin-Associated Bleeding With 4F-PCC Examined in Obese Patients

Reversal of Warfarin-Associated Bleeding With 4F-PCC Examined in Obese Patients

By

To investigate an appropriate dosing strategy for 4F-PCC (Kcentra; CSL Behring) in obese patients, the authors conducted a retrospective analysis comparing the reversal of warfarin using adjusted (N=28) vs actual body weight (N=50).

FDA Approves Generic Aminocaproic Acid Tablet

FDA Approves Generic Aminocaproic Acid Tablet

By

Aminocaprioc Acid Tablets are useful in enhancing hemostasis when fibrolysis contributes to bleeding.

Fluoroquinolones Tied to Increased Risk for Arrhythmia, CV Mortality

Fluoroquinolones Tied to Increased Risk for Arrhythmia, CV Mortality

By

To investigate the risk of cardiovascular adverse effects associated with this antibiotic class, researchers conducted a systematic review, meta-analysis, and network meta-analysis using studies identified through a search of MEDLINE, EMBASE, and the Cochrane Library.

Another Antihypertensive Recalled Due to Potentially Carcinogenic Impurity

Another Antihypertensive Recalled Due to Potentially Carcinogenic Impurity

By

The impurity was identified following laboratory testing conducted by the FDA; this is the first non-valsartan product that the Agency has found to contain NDEA.

More Articles by Diana Ernst, RPh

Sign Up for Free e-Newsletters